Polycystic Kidney Disease (PKD) Study

Polycystic Kidney Disease (PKD) Study

Polycystic Kidney Disease (PKD) Study

FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Qualified volunteers will receive at no cost:

  • Study medication
  • Study-related care from a local doctor
  • Reimbursement for your time and travel upto $1,960.00

If you are interested you should:

  • Be 18 to 70 years of age
  • Have been diagnosed with ADPKD

For more information, please visit or call our office at 614-487-2560 or email us at info@remdavis.com